Panacea Biotec to supply Pentavalent Vaccine Easyfive-TT to UNICEF

14 Feb 2014 Evaluate

Panacea Biotec, one of the leading research based health management companies of India, has received UNICEF award for supply of the company’s DTP-HepB-Hib (Pentavalent) Vaccine Easyfive-TT to UNICEF during the period 2014-2016. This award to the company is the outcome of the recent relisting of the its Pentavalent Vaccine by World Health Organisation (WHO) on October 02, 2013, post successful completion of the audit of the company’s Lalru and Baddi facilities conducted by WHO team from February 28 until March 01, 2013.

UNICEF is yet to award a part of the total forecast quantities for the above said period and the un-awarded quantities (including any potential additional requirement for India) will be awarded at a later stage in line with the demand forecast at such time. The suppliers performance across all vaccines supplied to UNICEF will also be taken into account when additional incremental awards are determined. The company has also started supplying Easyfive-TT to international markets against UNICEF purchase orders.

Panacea Biotec is one of India’s leading research based health management companies with established research, manufacturing and marketing capabilities.

Panacea Biotec Share Price

143.25 -2.90 (-1.98%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.